Ultrasensitive and specific fluorescence detection of a cancer biomarker via nanomolar binding to a guanidinium-modified calixarene

We designed a water-soluble guanidinium-modified calix[5]arene to target lysophosphatidic acid (LPA), an ideal biomarker for early diagnosis of ovarian and other gynecologic cancers, achieving binding on the nanomolar level. An indicator displacement assay, coupled with differential sensing, enabled...

Full description

Saved in:
Bibliographic Details
Published in:Chemical science (Cambridge) 2018-02, Vol.9 (8), p.2087-2091
Main Authors: Zheng, Zhe, Geng, Wen-Chao, Gao, Jie, Wang, Yu-Ying, Sun, Hongwei, Guo, Dong-Sheng
Format: Article
Language:English
Subjects:
Binding
Biomarkers
Calixarenes
Fluorescence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We designed a water-soluble guanidinium-modified calix[5]arene to target lysophosphatidic acid (LPA), an ideal biomarker for early diagnosis of ovarian and other gynecologic cancers, achieving binding on the nanomolar level. An indicator displacement assay, coupled with differential sensing, enabled ultrasensitive and specific detection of LPA. Moreover, we show that using a calibration line, the LPA concentration in untreated serum can be quantified in the biologically relevant low μM range with a detection limit of 1.7 μM. The reported approach is feasible for diagnosing ovarian and other gynecologic cancers, particularly at their early stages.
ISSN:2041-6520
2041-6539
DOI:10.1039/c7sc04989g